Biogen Pharmachem Industries Limited has confirmed its routine quarterly compliance regarding share dematerialization.

For the quarter ended June 30, 2026, the company's Registrar & Share Transfer Agent certified that no physical share certificates were submitted for conversion into electronic (demat) form.

This indicates a smooth quarter for share processing, reflecting stable back-office operations and continued adherence to market practices for investor convenience.